Research on the Development and Application of a Preoperative Assessment Model for Transcatheter Mitral Valve Edge-to-Edge Repair Based on Visual Foundation Models

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorBeijing Hospital

About this trial

Mitral regurgitation (MR) is the most prevalent valvular heart disease in China. Transcatheter edge-to-edge repair (TEER) is currently the preferred treatment for patients with severe MR who face high surgical risks. However, existing preoperative assessment methods for TEER suffer from numerous limitations, including complex measurement parameters, high technical demands, and significant subjectivity. Vision Mamba, a cutting-edge technology in the visual domain, overcomes the limitations of common computational units in convolutional neural networks and Transformers through bidirectional state space models and positional encoding, demonstrating exceptional performance in visual tasks. To date, no studies have applied Vision Mamba to ultrasound videos for constructing TEER preoperative assessment models. Our team previously established a Transformer-based evaluation model using a small, single-center cohort. This study innovatively introduces a Vision Mamba-based visual foundation model. By integrating multi-faceted, multi-modal ultrasound videos from multiple centers, we develop a one-stop preoperative TEER assessment model for MR patients \[slice identification → video analysis → multi-modal information fusion → preoperative assessment recommendation (suitable/challenging/unsuitable)\]. This model will optimize surgical patient identification and accurately screen patients with contraindications. Furthermore, the one-stop model is fast and objective, significantly improving clinical efficiency. It holds promise for deployment at primary care levels to optimize healthcare resource allocation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: 18-90 years

Patients with moderate to severe or severe mitral regurgitation as indicated by echocardiography

Disqualifiers

Moderate or severe aortic stenosis or aortic regurgitation, or following aortic valve replacement

Patients with congenital heart disease

Poor image quality: Insufficient cross-sectional coverage or inability to perform effective mitral valve marking

Trial population

The study population was drawn from Beijing Hospital and Fuwai Hospital of the Chinese Academy of Medical Sciences.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • Model Construction, Validation, and Optimization

    Other intervention

    Data from patients in this study will be used for model construction, validation, and optimization.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Echocardiography-related indicators

Time frame
Echocardiogram within 2-3 days after admission

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: